is retatrutide a glp-1 drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, CBS News investigation who makes retatrutide Demand for

The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice

Medicare Advantage plans have an incentive to code medical conditions in such a way that makes enrollees appear sicker than they would if they were in traditional Medicare, which means the estimate may be too high

If lots of people start microdosing, it could re-trigger a GLP-1 shortage and make it harder for people with diabetes to access the medication

It activates AMPK (AMP-activated protein kinase), the same metabolic sensor that metformin targets, which explains the overlapping effects

Whether discontinuation due to adverse events has affected the statistical analysis of weight regain still required further research for support

Fried Foods: Fried foods like fast food are high in calories and unhealthy fats like saturated fat and trans-fat